Research finds it doesnt increase depression or suicidal thoughts compared to placebo
What Results Can I Expect from Semaglutide and Tirzepatide Weight Loss
Safety Overall, 9 (69.2%) patients treated with GLP-1-RAs reported at least one AE
Semaglutide Has Additional Benefits Beyond Weight Loss According to research reported by Scientific American , weekly doses of semaglutide cut the risk of major cardiovascular events in overweight or obese patients with heart disease by 20%
Designed to Minimize Discomfort: One of the key advantages of microdosing is that it aims to deliver the appetite-supporting benefits of GLP-1 treatments while helping to reduce the likelihood of common side effects such as nausea or gastrointestinal discomfort
The following GLP-1 drugs have been FDA-approved for controlling blood glucose levels in people with Type 2 diabetes: Byetta (exenatide) Bydureon (exenatide extended-release) Victoza (liraglutide) Trulicity (dulaglutide) Ozempic (semaglutide) Rybelsus (oral semaglutide) Tanzeum (albiglutide) Adlyxin (lixisenatide) Soliqua (insulin glargine/lixisenatide combination) Xultophy (insulin degludec/liraglutide combination) In addition, the FDA has approved Mounjaro, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, for managing glycemic control in Type 2 diabetes
